Login or sign up
For business
Average ratingExcellent
4.5/ 5

Based on 8 reviews

563%
425%
313%
20%
10%
Ask AI

Questions about Yoshindo

Based on 8 reviews, listing data and website checks · updated 8 days ago

What is Yoshindo?

Yoshindo is a biopharmaceutical company focused on research and development for future pharmaceuticals. They specialize in contract manufacturing of biopharmaceuticals and operate YL Biologics, a joint venture with Rupin Limited of India. This joint venture has successfully developed biosimilars for treating rheumatoid arthritis, with YL Biologics handling manufacturing and sales in Japan.

What does the rating split and review timeline indicate for Yoshindo?

The Trustburn rating for Yoshindo is 4.5 out of 5 based on 8 reviews. The rating split includes five 5-star reviews, two 4-star reviews, and one 3-star review. The most recent review was posted on November 15, 2023, while the oldest was posted on December 21, 2022.

What is the official website of Yoshindo?

The official website of Yoshindo is yoshindo.co.jp.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Yoshindo

Toward the research and development required for pharmaceuticals in the future, Yoshindo is currently working on multiple biopharmaceutical businesses. One is contract manufacturing of biopharmaceuticals. This led to the start of an advanced approach to biopharmaceuticals that is unusual for a generic manufacturer. In addition, YL Biologics, a joint venture established with Rupin Limited of India, has succeeded in the global development of biosimilars for the treatment of rheumatoid arthritis, Emblem, and YL Biologics is in charge of manufacturing and sales in Japan.